Ulf Grawunder is the founder of NBE-Therapeutics. Latest round: Seed. Backed by Boehringer Ingelheim Venture Fund. Based in Basel, Switzerland.
Ulf Grawunder is the co-founder and former CEO of NBE-Therapeutics, a biotechnology company based in Basel. He led the company until its acquisition by Boehringer Ingelheim for EUR 1.2 billion in January 2021. He secured seed financing from the Boehringer Ingelheim Venture Fund in 2013.
Full founder directory · Investor directory · Company funding database · Fundraising library